New cancer clinical trial: A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

Published on: April 30, 2018 at 12:00PM
Condition:   Neuroendocrine Neoplasm
Interventions:   Drug: 18F-AlF-NOTA-octreotide;   Device: PET/CT
Sponsor:   Xiangya Hospital of Central South University
Recruiting
https://ift.tt/2I3Wgvj